SCHEMBL28166809

SCHEMBL28166809

CC(C)N1CCN(C(=O)OCc2ccccc2)CC1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
CYP2C19 P33261 1/20 0.51
PDE4B Q07343 1/20 0.47
HTT P42858 1/20 0.46
HTR2C P28335 2/20 0.46
MMP1 P03956 1/20 0.46
MMP3 P08254 1/20 0.46
MMP7 P09237 1/20 0.46
MMP9 P14780 1/20 0.46
MMP13 P45452 1/20 0.46
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3868582 0.89 PDK1 (0.53) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL3863607 0.89 PDK1 (0.53) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL28166614 0.83 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL28166801 0.81 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL28166631 0.80 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL1911481 0.80 MEN1 (0.61) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL28166666 0.79 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL4814264 0.79 MEN1 (0.76) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL3970912 0.79 MEN1 (0.76) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL7393652 0.79 MEN1 (0.76) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098886-A Quinazolinones PARP-1/2 inhibitor containing piperazinones and preparation method thereof, pharmaceutical composition and purposes 中国医学科学院药物研究所 2017-08-29 CN disclosed